Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

1

Revenue 2017

Pfizer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Pfizer's sales performance.

Pfizer

Pfizer expands access to lipid nanoparticle technology in new agreement with Acuitas Therapeutics

Pfizer expands access to lipid nanoparticle technology in new agreement with Acuitas Therapeutics Acuitas’ LNP technology is already used in the Pfizer/BioNTech COVID-19 vaccine, Comirnaty. ... is excited to be working with Pfizer to advance new vaccines and therapeutic products.”.

Pfizer/BioNTech confirm new global collaboration to develop first mRNA-based shingles vaccine

Pfizer/BioNTech confirm new global collaboration to develop first mRNA-based shingles vaccine Pfizer/BioNTech have announced the start of a new collaboration to develop a potential first mRNA-based prophylactic shingles vaccine. ... According to the terms of the agreement, Pfizer will pay BioNTech $225m in upfront costs, while BioNTech will pay

Pfizer/BioNTech receives expanded authorisation from the FDA for its COVID-19 booster

Pfizer/BioNTech receives expanded authorisation from the FDA for its COVID-19 booster As with Pfizer/BioNTech’s initial vaccine, the booster dose will have the same dosage strength of 30-µg. ... Bourla added that Pfizer “continue to believe that broad use of boosters is essential to preserving a high level of protection against this

US prefers mRNA COVID-19 vaccines over J&J

US prefers mRNA COVID-19 vaccines over J&J Citing concerns over blood clots, Americans are now advised that should get the Pfizer-BioNTech or Moderna vaccines in preference to Johnson and Johnson vaccine. ... However, the news seems to have caught Pfizer off-guard which said its talks with the EU

Emergency use of Paxlovid allowed in Europe

Emergency use of Paxlovid allowed in Europe Paxlovid, however, works intracellularly on the protease of the SARS-CoV-2 virus by inhibiting viral replication,” said Pfizer. ... The EMA also announced that it has started a ‘comprehensive rolling review’ ahead of a possible application for a

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

Research Partnership has joined Ashfield Advisory, the consulting division of healthcare marketing services company, Ashfield. As the market insights specialist...

Latest intelligence

When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...